KR20140107641A - Mogat-2 억제제로서 유용한 신규 모르폴리닐 유도체 - Google Patents

Mogat-2 억제제로서 유용한 신규 모르폴리닐 유도체 Download PDF

Info

Publication number
KR20140107641A
KR20140107641A KR1020147021129A KR20147021129A KR20140107641A KR 20140107641 A KR20140107641 A KR 20140107641A KR 1020147021129 A KR1020147021129 A KR 1020147021129A KR 20147021129 A KR20147021129 A KR 20147021129A KR 20140107641 A KR20140107641 A KR 20140107641A
Authority
KR
South Korea
Prior art keywords
mixture
mmol
added
compound
give
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020147021129A
Other languages
English (en)
Korean (ko)
Inventor
마리아 로사리오 곤잘레스-가르시아
마리아 카르멘 페르난데스
Original Assignee
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48905712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140107641(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 일라이 릴리 앤드 캄파니 filed Critical 일라이 릴리 앤드 캄파니
Publication of KR20140107641A publication Critical patent/KR20140107641A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020147021129A 2012-01-31 2013-01-24 Mogat-2 억제제로서 유용한 신규 모르폴리닐 유도체 Abandoned KR20140107641A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP12382037.5 2012-01-31
EP12382037 2012-01-31
US201261617093P 2012-03-29 2012-03-29
US61/617,093 2012-03-29
EP12382433 2012-11-06
EP12382433.6 2012-11-06
PCT/US2013/022828 WO2013116065A1 (en) 2012-01-31 2013-01-24 Novel morpholinyl derivatives useful as mogat-2 inhibitors

Publications (1)

Publication Number Publication Date
KR20140107641A true KR20140107641A (ko) 2014-09-04

Family

ID=48905712

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147021129A Abandoned KR20140107641A (ko) 2012-01-31 2013-01-24 Mogat-2 억제제로서 유용한 신규 모르폴리닐 유도체

Country Status (23)

Country Link
US (1) US8993568B2 (https=)
EP (1) EP2809661B1 (https=)
JP (1) JP5852269B2 (https=)
KR (1) KR20140107641A (https=)
CN (1) CN104080777B (https=)
AP (1) AP2014007793A0 (https=)
AU (1) AU2013215549B2 (https=)
BR (1) BR112014018712A8 (https=)
CA (1) CA2859992A1 (https=)
CL (1) CL2014001862A1 (https=)
CO (1) CO7020914A2 (https=)
CR (1) CR20140325A (https=)
DO (1) DOP2014000177A (https=)
EA (1) EA024182B1 (https=)
ES (1) ES2571577T3 (https=)
GT (1) GT201400169A (https=)
IL (1) IL233542A0 (https=)
MX (1) MX2014008604A (https=)
PE (1) PE20141789A1 (https=)
PH (1) PH12014501712B1 (https=)
SG (1) SG11201404508XA (https=)
WO (1) WO2013116065A1 (https=)
ZA (1) ZA201405227B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9073856B2 (en) 2012-01-23 2015-07-07 Eli Lilly And Company Phenyl methanesulfonamide derivatives useful as MGAT-2 inhibitors
AR089771A1 (es) 2012-01-31 2014-09-17 Lilly Co Eli Derivados de bencil sulfonamida utiles como inhibidores de mogat-2
JP5852269B2 (ja) 2012-01-31 2016-02-03 イーライ リリー アンド カンパニー Mogat−2阻害剤として有用な新規モルホリニル誘導体
MX2015005739A (es) 2012-11-06 2015-09-16 Lilly Co Eli Compuestos novedosos de bencil sulfonamida utiles como inhibidores de mogat-2.
US10335401B2 (en) 2015-12-21 2019-07-02 Shionogi & Co., Ltd. Non-aromatic heterocyclic derivative having MGAT2 inhibitory activity
TWI782056B (zh) 2017-07-14 2022-11-01 日商鹽野義製藥股份有限公司 具有mgat2抑制活性的縮合環衍生物
CA3126334A1 (en) 2019-01-11 2020-07-16 Shionogi & Co., Ltd. Dihydropyrazolopyrazinone derivative having mgat2 inhibitory activity

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889006A (en) 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
WO2000006539A1 (en) 1998-07-31 2000-02-10 Eli Lilly And Company Alkenyl sulphonamide derivatives
AU5235699A (en) 1998-07-31 2000-02-21 Eli Lilly And Company Sulfonamide derivatives
GB0408777D0 (en) 2004-04-20 2004-05-26 Glaxo Group Ltd Compounds
EP1659113A1 (en) 2004-11-08 2006-05-24 Evotec AG Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
EP1655283A1 (en) 2004-11-08 2006-05-10 Evotec OAI AG 11beta-HSD1 Inhibitors
US8232282B2 (en) 2006-09-28 2012-07-31 Dainippon Sumitomo Pharma Co., Ltd. Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the same
TW200831092A (en) * 2006-12-21 2008-08-01 Astrazeneca Ab Therapeutic agents
US20090203695A1 (en) * 2007-12-05 2009-08-13 Biovitrum Ab Compounds IV
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
EP2272841A1 (en) 2008-03-28 2011-01-12 Banyu Pharmaceutical Co., Ltd. Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
JP2011522006A (ja) 2008-06-04 2011-07-28 アストラゼネカ アクチボラグ 新規化合物v
US20110275647A1 (en) 2009-02-23 2011-11-10 Msd K.K. Pyrimidin-4-(3h)-one derivatives
JP2014051434A (ja) 2010-12-28 2014-03-20 Dainippon Sumitomo Pharma Co Ltd 二環性ピリミジン誘導体
US9073856B2 (en) 2012-01-23 2015-07-07 Eli Lilly And Company Phenyl methanesulfonamide derivatives useful as MGAT-2 inhibitors
JP5852269B2 (ja) 2012-01-31 2016-02-03 イーライ リリー アンド カンパニー Mogat−2阻害剤として有用な新規モルホリニル誘導体
AR089771A1 (es) 2012-01-31 2014-09-17 Lilly Co Eli Derivados de bencil sulfonamida utiles como inhibidores de mogat-2
MX2015005739A (es) 2012-11-06 2015-09-16 Lilly Co Eli Compuestos novedosos de bencil sulfonamida utiles como inhibidores de mogat-2.

Also Published As

Publication number Publication date
CN104080777B (zh) 2015-12-09
EA024182B1 (ru) 2016-08-31
CR20140325A (es) 2014-08-25
JP2015504917A (ja) 2015-02-16
ZA201405227B (en) 2016-05-25
EP2809661A1 (en) 2014-12-10
HK1199024A1 (zh) 2015-06-19
AP2014007793A0 (en) 2014-07-31
US8993568B2 (en) 2015-03-31
PH12014501712A1 (en) 2014-10-13
AU2013215549A1 (en) 2014-07-17
CA2859992A1 (en) 2013-08-08
PE20141789A1 (es) 2014-11-19
MX2014008604A (es) 2014-08-22
PH12014501712B1 (en) 2014-10-13
EP2809661B1 (en) 2016-04-06
IL233542A0 (en) 2014-08-31
GT201400169A (es) 2015-08-27
BR112014018712A2 (https=) 2017-06-20
AU2013215549B2 (en) 2015-09-03
DOP2014000177A (es) 2014-08-31
WO2013116065A1 (en) 2013-08-08
JP5852269B2 (ja) 2016-02-03
CO7020914A2 (es) 2014-08-11
ES2571577T3 (es) 2016-05-26
US20150005305A1 (en) 2015-01-01
BR112014018712A8 (pt) 2017-07-11
EA201491227A1 (ru) 2015-01-30
CN104080777A (zh) 2014-10-01
CL2014001862A1 (es) 2014-11-14
SG11201404508XA (en) 2014-10-30

Similar Documents

Publication Publication Date Title
JP7850663B2 (ja) スピロ環含有キナゾリン化合物
JP7085566B2 (ja) アポトーシス誘発剤
EP2513114B1 (en) Pyrrolo[2,3-d]pyrimidine compounds
CN104066719B (zh) 用作mogat-2抑制剂的苄基磺酰胺衍生物
JP7173350B2 (ja) Lpa1受容体を拮抗するウレア化合物
JP5852269B2 (ja) Mogat−2阻害剤として有用な新規モルホリニル誘導体
KR101797046B1 (ko) 중수소화된 페닐 아미노 피리미딘 화합물 및 이 화합물을 함유하는 약물 조성물
KR20190026827A (ko) 방향족 아세틸렌 또는 방향족 에틸렌계 화합물, 그의 중간체, 제조 방법, 약물 조성물 및 용도
WO2013112323A1 (en) Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors
JP2018536667A (ja) 重水素化されたBrigatinib誘導体、かかる誘導体を含む薬学的組成物、並びにそれらの使用
JP5635181B2 (ja) ニトロイミダゾール系化合物、その製造方法および用途
EP2917194B1 (en) Novel benzyl sulfonamide compounds useful as mogat-2 inhibitors
HUE025731T2 (en) Chromone derivatives useful in the treatment of diseases mediated by TCR-NCK interaction
WO1996028447A1 (en) Pyrrolocarbazole derivatives
CN109422753B (zh) 一类具有抑制并降解酪氨酸蛋白激酶jak1或jak2活性的化合物
JP2021509399A (ja) インドールアミン−2,3−ジオキシゲナーゼ阻害剤およびその調製方法と使用
JP2022115836A (ja) Lpa1受容体を拮抗するウレア化合物を有効成分として含有する医薬
HK1199024B (en) Novel morpholinyl derivatives useful as mogat-2 inhibitors
JP7716147B2 (ja) 置換されたイソインドリン-1,3-ジオン類pde4阻害剤及びその薬物応用

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20140728

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140728

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151113

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20160520

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee